IP Library Granted Patent US 8,757,146
Granted Patent B2
US 8,757,146 · App. 12/866,448 · Granted Jun 24, 2014

Circumferential aerosol device

Inventors: John D. Hoekman (Seattle, WA); Rodney J. Y. Ho (Mercer Island, WA)
Assignee: University of Washington through its Center for Commercialization
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,757,146
App. No.
12/866,448
Granted
Jun 24, 2014
Kind
B2
Abstract

The present application discloses devices and methods for delivering a therapeutic compound to the olfactory epithelium of an animal or human. The device having one or more channels for imparting a circumferential and axial velocity to the discharged fluid, and an outlet that discharges an aerosol spray having a circumferential and axial velocity as it enters the nasal cavity of a user. The device is designed to displace the air in the upper nasal cavity in order to specifically deposit a therapeutic agent on the olfactory epithelium while minimizing pressure and discomfort experienced by the user.

Claims (10)

1. A pressurized olfactory drug delivery device comprising:

(a) a reservoir containing a therapeutic compound;

(b) a container containing a pressurized propellant fluid;

(c) a delivery device defining a longitudinal axis and having:

(i) an exit opening at a proximal end of the delivery device,

(ii) a first channel having a distal end and a proximal end, the first channel extending from the distal end of the first channel at the reservoir to the proximal end of the first channel at the exit opening, and

(iii) a second channel having a distal end and a proximal end, the second channel extending from the distal end of the second channel at the container to the proximal end of the second channel at the exit opening, the first channel and the second channel in fluid communication with the exit opening; and

(d) a metering device configured for selectively discharging a circumferential helical flow of the pressurized propellant fluid through the second channel;

wherein the second channel receives at the distal end of the second channel and delivers at the proximal end of the second channel the circumferential helical flow, and the circumferential helical flow entrains a portion of the therapeutic compound through the first channel at the exit opening.

2. The pressurized olfactory drug delivery device of claim 1 , further comprising a plurality of outlets at the distal end of the second channel for discharging the pressurized propellant fluid.

Assignments (2)
CHANGE OF NAME Recorded Apr 25, 2022
From: IMPEL NEUROPHARMA, INC.
To: IMPEL PHARMACEUTICALS INC.
Reel/Frame 059790/0722 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 22, 2011
From: HOEKMAN, JOHN D.; HO, RODNEY J.Y.
To: UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION
Reel/Frame 025995/0700 →
Continuity (2)
Provisional Application 61027002 · Feb 7, 2008
Related Publication 20110048414A1 · Mar 3, 2011